SG Americas Securities’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

SG Americas Securities’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,705	Closed	-$455K	–	3792
2020 Q2	$455K	Sell	4,705 -8,612	-65%	-$718K	﹤0.01%	2177
2020 Q1	$624K	Sell	13,317 -13,434	-50%	-$861K	0.01%	1657
2019 Q4	$1.95M	Buy	26,751 +24,018	+879%	+$1.46M	0.02%	835
2019 Q3	$143K	Sell	2,733 -1,251	-31%	-$66.5K	﹤0.01%	2539
2019 Q2	$200K	Sell	3,984 -2,860	-42%	-$139K	﹤0.01%	2410
2019 Q1	$356K	Sell	6,844 -42,536	-86%	-$1.96M	﹤0.01%	2129
2018 Q4	$2.41M	Buy	+49,380	New	+$2.72M	0.02%	755
2018 Q3	–	Sell	-3,840	Closed	-$191K	–	3584
2018 Q2	$191K	Buy	+3,840	New	+$186K	﹤0.01%	2630
2018 Q1	–	Sell	-4,404	Closed	-$185K	–	3675
2017 Q4	$185K	Buy	+4,404	New	+$170K	﹤0.01%	2498

Other funds holding MYOK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

SG Americas Securities's MYOK Position: Q3 2020 in Review

SG Americas Securities sold out of MyoKardia, Inc. Common Stock (MYOK) in Q3 2020, closing a stake of 4,705 shares — an estimated $455K sold.

SG Americas Securities first reported a position in MYOK in Q4 2017 and held it in 9 quarters. The position peaked at $2.41M in Q4 2018. 237 funds tracked by Wall St. Rank hold MYOK as of Q3 2020.

SG Americas Securities reported no remaining MyoKardia, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
SG Americas Securities sold 4,705 MyoKardia, Inc. Common Stock shares in Q3 2020, an estimated $455K.
SG Americas Securities first reported a position in MyoKardia, Inc. Common Stock in Q4 2017 and held it in 9 quarters.
SG Americas Securities's MyoKardia, Inc. Common Stock position peaked at $2.41M in Q4 2018.
237 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q3 2020.

Based on SG Americas Securities's 13F filing for Q3 2020, filed 9 Nov 2020.